Hexahydro-1H-4,7-methanoinden-5(6H)-one

Catalog No.: 
ACCZSU062
CAS No.: 
13380-94-4
Molecular Formula: 
C10H14O
Molecular Weight: 
150.22
Hexahydro-1H-4,7-methanoinden-5(6H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$111.00In stockInquiry
500g98%$445.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameHexahydro-1H-4,7-methanoinden-5(6H)-one
IUPAC Nameoctahydro-5H-4,7-methanoinden-5-one
MDL No.MFCD00168034
Molecular FormulaC10H14O
Molecular Weight150.22
SMILESO=C1C2CC(C1)C3CCCC23
InChI KeyOMIDXVJKZCPKEI-UHFFFAOYSA-N
SynonymFT-0621557 | MFCD00168034 | Octahydro-4,7-methano-5H-inden-5-one | Corodane | GIE06H28OX | tricyclo[5.2.1.0 (2,6)]decan-8-one | Tricyclo[5.2.1.0(2,6)]decanone-8 | octahydro-5H-4,7-methanoinden-5-one | Tricyclo [5.2.1.02,6] decan-8-one | Tricyclo(5,2,1,0(2
CAS No.13380-94-4
PubChem CID96509

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352+P312+P362+P364-P501

Synthetic Route by SureRoute

1. ACCZSU062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBKIU316 route compound structure diagram
    ACBKIU31613380-89-7In Stock
  2. Then
  3. ACCZSU062 route product structure diagram
    ACCZSU06213380-94-4In Stock
Inquiry

2. ACCZSU062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCZSU062 route product structure diagram
    ACCZSU06213380-94-4In Stock
Inquiry

3. ACCZSU062 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCZSU062 route product structure diagram
    ACCZSU06213380-94-4In Stock
Inquiry

Comments (0)